glp-1 receptor agonists adverse effects glp 1 agonist long term side Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds Gastrointestinal Adverse Effects of GLP-1

Several mechanisms may contribute to the positive effects of GLP1RAs in preventing HF and influencing the outcomes for patients with either HFpEF or HFrEF

Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial

Liraglutide Safety and Efficacy in Patients With Non-Alcoholic Steatohepatitis (LEAN): A Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Study

For weight loss specifically, Phase 2 trial data suggests retatrutide produces greater average weight loss (22-24%) compared to tirzepatide (18-22%) at maximum doses

Ive had a few patients with bulimia, and its not certain whether it would be safe or not to put them on it, Jay said

So it was a twice-a-day shot, which barely cleared the hurdle of good enough to be a drug, but we made it into a drug along with our partner Amylin and launched that in 2006